Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -14.459% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCCN(C(=O)CSc1nc2cc(S(=O)(=O)N(CC)CC)ccc2o1)C1CCS(=O)(=O)C1
b.) Nc1nnc(-c2ccco2)s1
Answer: a. CCCN(C(=O)CSc1nc2cc(S(=O)(=O)N(CC)CC)ccc2o1)C1CCS(=O)(=O)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCN(C(=O)CSc1nc2cc(S(=O)(=O)N(CC)CC)ccc2o1)C1CCS(=O)(=O)C1
CCCN(C(=O)CSc1nc2cc(S(=O)(=O)N(CC)CC)ccc2o1)C1CCS(=O)(=O)C1
2-[[5-(diethylsulfamoyl)-1,3-benzoxazol-2-yl]sulfanyl]-N-(1,1-dioxothiolan-3-yl)-N-propylacetamide